New data largely excludes nurse practitioners and physician assistants
By Charles Ornstein | @charlesornstein | Pro Publica
New data on drug and device company payments to doctors largely excludes nurse practitioners and physician assistants, though they play an ever-larger role in health care.
One advanced-practice nurse pleaded guilty last month to taking drug company kickbacks.
NOTE: This story was co-published with NPR’s Shots blog.
More:
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- PRACTICES: www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: www.CertifiedMedicalPlanner.org
- FINANCE: Financial Planning for Physicians and Advisors
- INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
- Dictionary of Health Economics and Finance
- Dictionary of Health Information Technology and Security
- Dictionary of Health Insurance and Managed Care
Although this book targets physicians, I was pleased to see that it also addressed the risk management, financial planning and employment benefit needs of nurses; physical, respiratory, and occupational therapists; CRNAs, hospitalists, and other members of the health care team….highly readable, practical, and understandable.
Nurse Cecelia T. Perez RN [Hospital Operating Room Manager, Ellicott City, Maryland
Filed under: Drugs and Pharma, Research & Development, Risk Management | Tagged: Charles Ornstein, drug company kickbacks, Drugs and Pharma, health fraud, Pharma Payments |
State Healthcare Price Transparency Grades
The Catalyst for Payment Reform and the Health Care Incentives Improvement Institute just released their third annual report card on state price transparency laws. Here are key features of the report:
• 90% of states (45) fail to provide adequate price information to consumers.
• In 2013, 29 states received an F score for price transparency.
• Massachusetts dropped from a B to an F when it put responsibility for price transparency on health plans.
• After getting an F in 2014, New Hampshire received the only A on the list for launching NH HealthCost.
• About one-third of patients currently receive some degree of pricing information.
• 80% say they valued price transparency on par with bedside manner in choosing a healthcare provider.
Source: Health Care Incentives Improvement Institute, July 8, 2015
LikeLike
Despite Physician Objections, Nurse Scope of Care Increases
Despite objections from physician groups, many states have enacted legislation that expands the range of care nurses are allowed to provide to their patients. According to The Washington Post, both West Virginia and Florida have recently enacted laws that allow advance practice nurses to establish primary care practices independent of physician oversight and to prescribe medications more freely, expanding the list of states that allow nearly full scope of practice to nurse practitioners to 21.
States that have passed legislation expanding the range of services that nurses can provide cite a need for primary care in rural areas that generally do not attract enough physicians to meet patient needs. These measures passed despite strident opposition from the American Medical Association, which maintains that nurses should coordinate with physicians as part of an integrated care team.
Source: Univadis [3/29/16] via Washington Post via PMNews #5,634
LikeLike